The effect of gentamicin and methylprednisolon on vertigo.
Phase 3
- Conditions
- Meniere,s disease.Meniere,s disease
- Registration Number
- IRCT2015041021582N1
- Lead Sponsor
- Deputy for research of Avaz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Patients with unilateral meniere's disease;
Exclusion criteria: patients with bilateral meniere's disease; patients whose involved ear is the only hearing ear; not suffering from central nervous system disease; dissatisfaction
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Vertigo. Timepoint: before treatment and 3 months later. Method of measurement: Questennaire.
- Secondary Outcome Measures
Name Time Method Tinnitus. Timepoint: before treatment and 3 month later. Method of measurement: Questennaire.;Hearing loss. Timepoint: before treatment and 3 month later. Method of measurement: audiometry.